Evidence map›Paper›PMID 33665120›Full record

ArticleMolecular genetics and metabolism reports2021

Aldolase A deficiency: Report of new cases and literature review.

C Papadopoulos, M Svingou, K Kekou, S Vergnaud, S Xirou, G Niotakis, G K Papadimas

Open access · goldAbstract readCase Reports
In one paragraph

Article in Molecular genetics and metabolism reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Glycogen storage diseases.Nature reviews. Disease primers · 2023
    Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

C Papadopoulos1st Department of Neurology, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, Greece.
M SvingouLaboratory of Medical Genetics, Medical School, National and Kapodistrian University of Athens, "Aghia Sophia" Children's Hospital, Athens, Greece.
K KekouLaboratory of Medical Genetics, Medical School, National and Kapodistrian University of Athens, "Aghia Sophia" Children's Hospital, Athens, Greece.
S VergnaudDépartement de Biochimie, Toxicologie et Pharmacologie, CHU de Grenoble, Centre de Référence Rhône-Alpes des Maladies NeuroMusculaires, Grenoble, France.
S Xirou1st Department of Neurology, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, Greece.
G NiotakisPediatric Neurology Clinics, Venizeleion General Hospital, Heraklion, Crete, Greece.
G K Papadimas1st Department of Neurology, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, Greece.
Eginition Hospital · GRNational and Kapodistrian University of Athens · GRCentre Hospitalier Universitaire de Grenoble · FRThe General Hospital of Heraklion "Venizeleio-Pananio" · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aldolase A (ALDOA), is the predominant isoform of aldolase in skeletal muscle and erythrocytes that catalyzes the reversibleconversion of fructose-1,6-bisphosphate to glyceraldehyde 3-phosphate. Autosomal recessive mutations in

Indexed as

Aldolase AAldolase A, ALDOAelectromyography, EMGglycogen storage disease type, GSDHemolytic anemiaRhabdomyolysis

Identifiers

PMID33665120
PMCPMC7907525
OpenAlexW3129596221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.